Elsevier

Kidney International

Volume 66, Issue 3, September 2004, Pages 924-934
Kidney International

Perspectives in Renal Medicine
Renal angiomyolipomata

https://doi.org/10.1111/j.1523-1755.2004.00838.xGet rights and content
Under an Elsevier user license
open archive

Renal angiomyolipomata. Renal angiomyolipomata can exist as an imaging curiosity or represent a life-threatening condition. There are likely over 10 million people world-wide who have a renal angiomyolipomata and approximately one tenth of these people also have tuberous sclerosis complex. The optimum treatment of angiomyolipomata is focused on sparing renal tissue and has included no intervention, both total and partial nephrectomy, and embolization. As basic science investigation into the biology of angiomyolipomata progresses, there is even hope for successful drug therapy. Because these renal lesions can be associated with other organ system dysfunction, a number of medical specialists become involved in the care of affected patients. The purpose of this article is to update the nephrologist on the molecular understanding of renal angiomyolipomata and for the possibilities of pharmacologic therapy in the future.

KEYWORDS

angiomyolipomata
tuberous sclerosis complex
lymphangioleiomyomatosis
oncocytoma
epithelioid
PEComa

Cited by (0)